ABOUT RHOE

The consultation ends. The care shouldn't.

Patients leave clinic with good plans and very little support at home. Rhoe gives every patient their clinician's plan as a voice they can talk to, in their own language, with the clinician still in charge.

WHY WE STARTED

It began in a physio clinic.

Our founder, Ademola, is an MSK physiotherapist. Again and again he saw patients leave with a clear plan, then struggle alone at home: unsure about an exercise, worried about a symptom, or unable to read a leaflet written in English.

AI assistants already help people shop, travel and work. Healthcare needs different rules: follow the clinician's plan, stay inside its limits, and call the care team in when something's wrong. That's what we're building.

WHAT WE BELIEVE

Four rules we build by.

01

Clinicians stay in charge

Rhoe follows the plan. It never writes its own.

02

Voice first

Talking is easier than typing, especially when you're in pain.

03

Every language

Good care shouldn't depend on reading English.

04

Proven, not promised

We test with clinicians and patients before we scale.

THE TEAM

Clinical care, AI engineering and health evidence.

Ademola Abass

Ademola Abass

FOUNDER · CLINICAL PRODUCT LEAD

MSK physiotherapist (DPT, University of Montana) and product founder.

Raphael Ariguzor

Raphael Ariguzor

CO-FOUNDER · CTO

Lead AI Engineer at SmartSearch UK. Builds safe, reliable AI systems used in the real world.

Mary Akinwola

Mary Akinwola

CO-FOUNDER · EVIDENCE-GENERATION

Digital health expert (MSc HSIE, University of Oxford, Distinction). She makes sure Rhoe is clinically meaningful and proven with real outcomes.

WHERE WE ARE

From pre-pilot to the NHS.

Done

Pre-pilot with real patients

30+ MSK patients with Rehabify in Nigeria. 90% reported a good experience.

Now

Clinician safety testing

GPs, FCPs and physiotherapists test Rhoe's replies and red-flag handling.

Next

NHS primary care pilot

A full pilot with an NHS Primary Care Network, starting with MSK.

Want to work with us?
We'd love to hear from you.